Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program

INTRODUCTION: Despite vaccination, there were more than 100,000 annual cases of varicella in the United States in 2013–2014. Individuals at highest risk of developing severe or complicated varicella include immunocompromised people, preterm infants, and pregnant women. Varicella zoster immune globul...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Myron J., Duchon, Jennifer M., Swamy, Geeta K., Gershon, Anne A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608934/
https://www.ncbi.nlm.nih.gov/pubmed/31269033
http://dx.doi.org/10.1371/journal.pone.0217749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608934/
https://www.ncbi.nlm.nih.gov/pubmed/31269033
http://dx.doi.org/10.1371/journal.pone.0217749

Ejemplares similares